๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of 6-Mercaptopurine in Patients with Inflammatory Bowel Disease Previously Intolerant of Azathioprine

โœ Scribed by David G. Bowen; Warwick S. Selby

Book ID
110225958
Publisher
Springer US
Year
2000
Tongue
English
Weight
43 KB
Volume
45
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Increased dosing requirements for 6-merc
Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger
โœ Andrew B. Grossman; Angela J. Noble; Petar Mamula; Robert N. Baldassano ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 83 KB

## Background: 6-mercaptopurine (6-mp) and its prodrug azathioprine (aza) are effective for the induction and maintenance of remission and reduction of corticosteroid exposure for pediatric inflammatory bowel disease (ibd). the standard dose of 6-mp is 1.0-1.5 mg/kg/day and for aza is 2.0-2.5 mg/kg